New research supports the feasibility of using coronary sinus aspiration (CSA) to remove around one-third of the contrast given during coronary angiography—thereby potentially reducing the risk of ...

New data from the PRESERVE trial suggest that administration of N-acetylcysteine and/or sodium bicarbonate does not reduce the incidence of acute kidney injury in patients with chronic kidney disease ...

Contrast-induced nephropathy is rare. It results from exposure to contrast dyes during certain imaging tests and cardiology procedures. People living with diabetes or advanced kidney disease may be at ...

Contrast-induced nephropathy (CIN) can be safely reduced in patients with chronic kidney disease and heart failure undergoing coronary procedures by guiding fluid administration with central venous ...

The use of iodinated contrast material in computed tomography (CT) did not increase patient risk for acute kidney injury (AKI), dialysis, or death, even among patients with poor renal function or ...

Please provide your email address to receive an email when new articles are posted on . The FDA is now requiring that gadolinium-based contrast agents carry new label warnings about the risk for ...

Computed Tomography (CT) scans can be performed either with the contrast or without the contrast. Contrast CT scans are performed to get a detailed image of the inside of your body and the blood ...

Contrast agents used in X-ray and other methods of imaging could increase the risk of developing dementia by 2.09 times, researchers said yesterday. Contrast agents are widely used in clinical testing ...

Experts have provided new guidance in the use of contrast agents during MRI scans. Emerging research suggests gadolinium-based contrast agents, injected in a patient's veins to brighten tissues in MRI ...